Insulet Statistics
Total Valuation
Insulet has a market cap or net worth of $19.84 billion. The enterprise value is $20.32 billion.
Important Dates
The last earnings date was Thursday, February 20, 2025, after market close.
Earnings Date | Feb 20, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Insulet has 70.14 million shares outstanding. The number of shares has increased by 0.35% in one year.
Current Share Class | 70.14M |
Shares Outstanding | 70.14M |
Shares Change (YoY) | +0.35% |
Shares Change (QoQ) | +0.17% |
Owned by Insiders (%) | 0.27% |
Owned by Institutions (%) | 102.86% |
Float | 69.84M |
Valuation Ratios
The trailing PE ratio is 48.93 and the forward PE ratio is 66.54. Insulet's PEG ratio is 2.16.
PE Ratio | 48.93 |
Forward PE | 66.54 |
PS Ratio | 9.57 |
Forward PS | 8.34 |
PB Ratio | 16.38 |
P/TBV Ratio | 18.69 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | 2.16 |
Financial Ratio History Enterprise Valuation
EV / Earnings | 48.57 |
EV / Sales | 9.81 |
EV / EBITDA | 52.36 |
EV / EBIT | 65.77 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.58, with a Debt / Equity ratio of 1.18.
Current Ratio | 3.58 |
Quick Ratio | 2.50 |
Debt / Equity | 1.18 |
Debt / EBITDA | 3.61 |
Debt / FCF | n/a |
Interest Coverage | 96.53 |
Financial Efficiency
Return on equity (ROE) is 43.03% and return on invested capital (ROIC) is 8.00%.
Return on Equity (ROE) | 43.03% |
Return on Assets (ROA) | 6.80% |
Return on Invested Capital (ROIC) | 8.00% |
Return on Capital Employed (ROCE) | 12.07% |
Revenue Per Employee | $690,533 |
Profits Per Employee | $139,433 |
Employee Count | 3,000 |
Asset Turnover | 0.73 |
Inventory Turnover | 1.50 |
Taxes
Income Tax | -118.10M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +47.13% in the last 52 weeks. The beta is 1.23, so Insulet's price volatility has been higher than the market average.
Beta (5Y) | 1.23 |
52-Week Price Change | +47.13% |
50-Day Moving Average | 273.04 |
200-Day Moving Average | 228.91 |
Relative Strength Index (RSI) | 54.94 |
Average Volume (20 Days) | 598,244 |
Short Selling Information
The latest short interest is 2.44 million, so 3.48% of the outstanding shares have been sold short.
Short Interest | 2.44M |
Short Previous Month | 2.60M |
Short % of Shares Out | 3.48% |
Short % of Float | 3.50% |
Short Ratio (days to cover) | 4.49 |
Income Statement
In the last 12 months, Insulet had revenue of $2.07 billion and earned $418.30 million in profits. Earnings per share was $5.78.
Revenue | 2.07B |
Gross Profit | 1.45B |
Operating Income | 308.90M |
Pretax Income | 267.50M |
Net Income | 418.30M |
EBITDA | 387.97M |
EBIT | 308.90M |
Earnings Per Share (EPS) | $5.78 |
Full Income Statement Balance Sheet
The company has $953.40 million in cash and $1.43 billion in debt, giving a net cash position of -$478.10 million or -$6.82 per share.
Cash & Cash Equivalents | 953.40M |
Total Debt | 1.43B |
Net Cash | -478.10M |
Net Cash Per Share | -$6.82 |
Equity (Book Value) | 1.21B |
Book Value Per Share | 17.27 |
Working Capital | 1.36B |
Full Balance Sheet Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 69.79%, with operating and profit margins of 14.91% and 20.19%.
Gross Margin | 69.79% |
Operating Margin | 14.91% |
Pretax Margin | 14.49% |
Profit Margin | 20.19% |
EBITDA Margin | 18.73% |
EBIT Margin | 14.91% |
FCF Margin | n/a |